Spectral Med Valuation
| EDT Stock | CAD 0.57 0.02 3.64% |
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Spectral Med current Real Value cannot be determined due to lack of data. The regular price of Spectral Med is C$0.57. Our model measures the value of Spectral Med from inspecting the company fundamentals such as Current Valuation of 163.21 M, shares owned by insiders of 18.13 %, and Return On Equity of -9.74 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Spectral Med's valuation include:
Price Book 49.8661 | Enterprise Value 163.2 M | Enterprise Value Ebitda (7.51) | Price Sales 84.7999 | Enterprise Value Revenue 81.3606 |
Undervalued
Today
Please note that Spectral Med's price fluctuation is out of control at this time. Calculation of the real value of Spectral Med is based on 3 months time horizon. Increasing Spectral Med's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Spectral Med is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Spectral Stock. However, Spectral Med's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.57 | Real 0.0 | Hype 0.0 | Naive 0.59 |
The intrinsic value of Spectral Med's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Spectral Med's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Spectral Med helps investors to forecast how Spectral stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Spectral Med more accurately as focusing exclusively on Spectral Med's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Spectral Med's intrinsic value based on its ongoing forecasts of Spectral Med's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Spectral Med's closest peers.
Spectral Med Cash |
|
Spectral Valuation Trend
Knowing Spectral Med's actual value is paramount for traders when making sound investment determinations. Using both Spectral Med's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Spectral Med Total Value Analysis
Spectral Med is currently anticipated to have takeover price of 163.21 M with market capitalization of 161.2 M, debt of 8.56 M, and cash on hands of 3.8 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Spectral Med fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
163.21 M | 161.2 M | 8.56 M | 3.8 M |
Spectral Med Investor Information
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.1. Spectral Med last dividend was issued on the 19th of December 2011. Based on the measurements of operating efficiency obtained from Spectral Med's historical financial statements, Spectral Med may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Spectral Med Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Spectral Med has an asset utilization ratio of 30.67 percent. This suggests that the Company is making C$0.31 for each dollar of assets. An increasing asset utilization means that Spectral Med is more efficient with each dollar of assets it utilizes for everyday operations.Spectral Med Ownership Allocation
Spectral Med shows a total of 282.82 Million outstanding shares. Spectral Med has 18.13 % of its outstanding shares held by insiders and 12.95 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Spectral Med Profitability Analysis
The company reported the revenue of 1.6 M. Net Loss for the year was (15.66 M) with profit before overhead, payroll, taxes, and interest of 983 K.About Spectral Med Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Spectral Med. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Spectral Med based exclusively on its fundamental and basic technical indicators. By analyzing Spectral Med's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Spectral Med's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spectral Med. We calculate exposure to Spectral Med's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Spectral Med's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 662 K | 628.9 K | |
| Pretax Profit Margin | (9.70) | (9.22) | |
| Operating Profit Margin | (7.15) | (6.79) | |
| Net Loss | (9.80) | (9.31) | |
| Gross Profit Margin | 0.41 | 0.78 |
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.